chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chest pain; This non-serious case was reported by a physician via sales rep and described the occurrence of chest pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced chest pain (Verbatim: Chest pain). The outcome of the chest pain was not reported.   It was unknown if the reporter considered the chest pain to be related to Shingrix.   It was unknown if the company considered the chest pain to be related to Shingrix.   Additional Information: GSK Receipt Date: 17-AUG-2023 The reporter reported that the patient received Shingrix vaccine and experienced severe chest pain. The reporter consented to follow up.
Welts itch really bad/itching is on the inside; Welts all over the body/welts on butt, arm and ankles/welts go away and pop up somewhere else; Patient took 2nd dose of moderna after 37 days of 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Welts itch really bad/itching is on the inside), URTICARIA (Welts all over the body/welts on butt, arm and ankles/welts go away and pop up somewhere else) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient took 2nd dose of moderna after 37 days of 1st dose) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 025L20A) for COVID-19 vaccination.     The patient's past medical history included Hypersensitivity reaction and Urticaria. Concurrent medical conditions included Diabetes (Condition improvement) since 17-Dec-1985, Hypertension (Condition at goal) on 18-Oct-2019 and Drug allergy (Hives) in 1988. Concomitant products included INSULIN HUMAN (INSULIN [INSULIN HUMAN]) for Diabetes, METFORMIN HYDROCHLORIDE (METFORMIN ER) and ATORVASTATIN for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient took 2nd dose of moderna after 37 days of 1st dose). On an unknown date, the patient experienced PRURITUS (Welts itch really bad/itching is on the inside) and URTICARIA (Welts all over the body/welts on butt, arm and ankles/welts go away and pop up somewhere else). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL LOTION N) (topical) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEK) (oral) at an unspecified dose and frequency. At the time of the report, PRURITUS (Welts itch really bad/itching is on the inside) and URTICARIA (Welts all over the body/welts on butt, arm and ankles/welts go away and pop up somewhere else) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient took 2nd dose of moderna after 37 days of 1st dose) had resolved. Not Provided          The patient was taking high blood pressure medicine concomitantly.   This case was linked to MOD-2021-092419 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Significant Follow up received on 20-jul-2021, updated patient demographic, suspect drug taken date was updated, New event added, clinical course of the events updated
This spontaneous report as received from a physician via field representative refers to a 70 year old male patient. On 20-AUG-2013, the patient was vaccinated with ZOSTAVAX 1 single shot, subcutaneous injection. 09-JUL-2014, the patient came into the physician's office experiencing jaw pain while using ZOSTAVAX. On 11-JUL-2014, the patient developed a rash on the right side of his face and through the eye, went to ER (emergency room) and was diagnosed with shingles. On an unknown date, the patient was treated for the adverse event with prednisone (manufacturer unknown) and acyclovir. The outcome of the patient developed rash on the right side of his face and through the eye, went to ER and was diagnosed with shingles and jaw pain while using ZOSTAVAX was reported as recovering/resolving. The reporter considered the events as disabling. Additional information is not expected because reporter refused additional contact.
This spontaneous report as received from a healthcare worker (medical assistant) refers to 3 unspecified patients of unknown age and gender. On 11-NOV-2014 the patients were vaccinated with ROTATEQ, route default as oral, (lot# dose and dose# unspecified) that were exposed to temperatures outside the proper storage range. No adverse effect reported. The outcome of the event was not reported. This is one of several reports received from the same source. Additional information has been requested.
HIVES, SWELLING, ITCHING TO 90% OF UPPER AND LOWER BODY.
My symptoms lasted 7 days. I had muscle aches, nausea and vomiting, fever 101-104 degrees. My lymph node under my arm swelled to the size of a baseball.
My daughter was vaccinated in the late afternoon.  She was very sleepy afterward and had no appetite.  I put her to bed around 7:00 PM and watched her on the baby monitor.  At approximately 11:00 PM I tried to offer her milk, as she was exclusively breastfed, but she would not wake up to eat.  I decided to change her diaper, thinking that might help to rouse her.  But she did not wake up.  This was highly unusual for her, as she was always a very light sleeper.  I called the nurse's line at my pediatrician's office and she advised me to turn on the lights, undress her, rub her skin, and make some noise as to make her uncomfortable.  It took 10-15 minutes to get her to wake up and give an appropriate response by crying.
Shot was very high up toward shoulder. Shooting pain at time of shot.  Since shot, entire arm is tingly with numb feeling. Painful to lift arm and cross arm over chest.  Not the typical pain that I have had from a flu shot.
Post vax, 24 hours later, pt developed fatigue, dull headache, diarrhea and nausea. At site of injection, she has a rash, 9cm X 4cm.
LEFT SIDED CHEST PAIN, SHORTNESS OF BREATH, FELT WARM AND FLUSHED
Follow-up information was received that provided patient gender, suspect vaccines, additional events and laboratory test results. This case was considered medically important. Medical records regarding Hib were received from an attorney regarding a male patient received the fourth dose on 25-Oct-2000 along with the third dose of IPOL (manufacturer unknown) and the fourth dose of DTaP (manufacturer unknown) at the age of 17 months and experienced encephalopathy, pervasive developmental disorder NOS, autism, neurodevelopmental disorder, pica, delayed language and mercury poisoning. On 25-Oct-2000, the patient received the fourth dose of Hib along with other childhood vaccines. The child received vaccines from birth up to 18 months of age, age allegedly  experienced mercury poisoning as a  result of the cumulative exposure to mercury in the vaccines. On an unspecified date, the patient experienced autism, neurodevelopmental disorder, pica, and delayed language. In Nov-2001, the child was diagnosed with encephalopathy. In Jan-2002, the patient was diagnosed with pervasive developmental disorder NOS. It was unknown if the patient recovered from the events. DNA test fragile X (results: negative) was done on 06-Feb-2002. Blood lead (results: 5 ug/dL) was done in 24-Feb-2003. No additional information was available at the time of this report.
Recipient received dose #2 vaccine today, and almost immediately had response with witnessed seizure-like activity, with posturing, tonic-clonic movement of his upper extremities, and eye movement with lateral nystagmus. Loss of consciousness was noted. Symptoms lasted approximately 15-30 seconds, and patient was placed in a reclined position. He regained consciousness quickly and became pale and diaphoretic. He was normally responsive and answered questions appropriately. Initial BP 74/32, HR 38, SpO2 98%. He drank some Gatorade and had improvement of symptoms gradually over 15-20 minutes. Repeat BP 100/58, HR 78. No past history of seizures. One prior syncopal event after pain response with sports injury. No prior difficulty with dose #1. After recovery, patient reported immediate pain with vaccine administration, then vision went blurry and he lost consciousness. Mother was driving the vehicle, and she witness symptoms as well as nursing staff in the vaccine pod. After recovery, options for further medical evaluation were discussed given complicated vasovagal response with seizure-like activity, mother called pediatrician to see if he could be seen, they recommended ER. Mother chose to drive by personal vehicle, rather than EMS transport. Symptoms were fully resolved and patient was transported to ER for further evaluation by personal vehicle.
diagnosis (04May2022) of Hailey- Hailey disease/ Symptoms manifested (and persisted) starting a few weeks after initial two dose; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 53-year-old male patient received BNT162b2 (BNT162B2), on 16Feb2021 as dose 2, single (Lot number: EL9264) and on 26Sep2021 as dose 3 (booster), single (Lot number: FF2588) at the age of 53 years for covid-19 immunisation. The patient's relevant medical history included: "some adhesives" (unspecified if ongoing), notes: known allergies: some adhesives; "Fungal disease" (unspecified if ongoing), notes: Antifungal cream'. The patient took concomitant medications. Vaccination history included: BNT162b2 (Dose: 1, Manufacturer: Pfizer, Lot number: EL3247), administration date: 26Jan2021, when the patient was 53-year-old, for COVID-19 immunization. The following information was reported: BENIGN FAMILIAL PEMPHIGUS (non-serious) with onset 31May2021, outcome "not recovered", described as "diagnosis (04May2022) of Hailey- Hailey disease/ Symptoms manifested (and persisted) starting a few weeks after initial two dose". The event "diagnosis (04may2022) of hailey- hailey disease/ symptoms manifested (and persisted) starting a few weeks after initial two dose" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of benign familial pemphigus. Additional information: If other vaccine in four weeks: No. Other medications in two weeks: anti-fungal cream. Adverse event: New diagnosis (04May2022) of Hailey- Hailey disease. Symptoms manifested (and persisted) starting a few weeks after initial two dose covid vaccination. Multiple failed diagnoses prior to biopsy and today's diagnosis. Previous example of exacerbation noted in [site name]. AE treatment: medications. If covid prior vaccination: No. If covid tested post vaccination: Yes. known allergies: some adhesives.
2 hours after vaccine given came to health office complaining of itching at site. Redness, edema and warmth present.
Everyone I know who gets the shot, gets the flu; Initial information received on 14-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a non-hcp (healthcare professional).  This case involves unknown gender adult patient for whom reporter stated everyone I know who gets the shot, gets the flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number; formulation; strength; expiry date not reported) via unknown route in unknown administration site. Information on batch number was requested.  On an unknown date the patient developed a non-serious event "everyone I know who gets the shot, gets the flu" (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "I never get the shot and I don't get the flu. Everyone I know who gets the shot, gets the flu."  It is unknown if there were lab data/results available.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (Everyone I know who gets the shot, gets the flu).  At time of reporting, the outcome was Unknown for the event everyone i know who gets the shot, gets the flu.
On July 4th I believe I contracted covid 19. I have been quite sick (high fever, chills, cough, respiratory symptoms); On July 4th I believe I contracted covid 19. I have been quite sick (high fever, chills, cough, respiratory symptoms); I have been quite sick (high fever, chills, cough, respiratory symptoms); On July 4th I believe I contracted covid 19. I have been quite sick (high fever, chills, cough, respiratory symptoms); On July 4th I believe I contracted covid 19. I have been quite sick (high fever, chills, cough, respiratory symptoms); On July 4th I believe I contracted covid 19. I have been quite sick (high fever, chills, cough, respiratory symptoms); On July 4th I believe I contracted covid 19. I have been quite sick (high fever, chills, cough, respiratory symptoms); This is a spontaneous report from a Pfizer sponsored program COVAX US support.   A 28-years-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 02Feb2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on Jan2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient received vaccine in Jan2021 and was fully vaccinated 02Feb2021. The patient was so excited and so grateful for the vaccine and protection. On 04Jul2021, the patient believe he/she contracted covid 19. The patient has been quite sick (high fever, chills, cough, respiratory symptoms). The patient was also 28 and in good health. Hopefully the patient's story could push for a booster to the vaccine for others and myself. The outcome of the events was unknown.   Information about lot/batch number has been requested.
took COVID test yesterday and tested positive with symptoms; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's mother) reported for a 16-year-old female patient (reporter's daughter). This is the second case out of the 2 cases.  A 16-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0198), dose 1 via an unspecified route of administration on 27Jul2021 (at the age of 16-years-old) as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced "took COVID test yesterday and tested positive with symptoms" on 01Aug2021. The consumer took her daughter (patient), she got her shot, the vaccine on the 27. She thought it was the Tuesday or Wednesday of the previous week and the previous day. The consumer reported that unfortunately after taking the first dose her daughter experienced side effects. On the night of vaccination, the patient threw up. She was little nauseated and had body ache. She did not had lot of temperature like she was gone up to maybe 98 point something but that was or 99 but that was it. She was been getting to like middle cough and she just did not feel good. The consumer took her to get COVID shot and she tested positive for COVID. The patient underwent lab tests and procedures which included body temperature: gone up to 98 point something but that is or 99 (gone up to maybe 98 point something but that is or 99 but that is it) in Jul2021 and sars-cov-2 test: positive on 01Aug2021. So the consumer's question was what she from here on, she mean do they tested positive for COVID. Has to be (incomplete sentence). She also asked when do her daughter have to take the other shot. The outcome of the event was unknown.
woke up left side of face was numb and tingling  like a shot of novocaine.
Whelps appeared on his right arm and legs. They were large and very noticeable. He was treated in the Emergency department with a Medrol Dose pack, and steroid injection.
Pulse of 100, high pulse; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Pulse of 100, high pulse) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 084J21A and 060H21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LOSARTAN and HYDROCHLOROTHIAZIDE for Blood pressure management.   On 15-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2022, the patient experienced HEART RATE INCREASED (Pulse of 100, high pulse) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (Pulse of 100, high pulse) outcome was unknown and CHILLS (Chills) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2022, Blood pressure measurement: 85/75 (Low) Patient  blood pressure was 85/75. In January 2022, Heart rate: 100 (High) Reported that it is not normal , patient has high pulse.         Patient reported chills, and she is kind of out of it.   This case was linked to MOD-2022-452229 (Patient Link).
No additional AEs; inadvertently administered an expired dose of MMR II; This spontaneous report as received from a customer referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, current condition, drug reactions/allergies and concomitant medication were not provided.         On 02-AUG-2021, the patient was vaccinated with expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) 1 time dose (dose, strength, route of administration and anatomical site of vaccination were not reported, lot # S023656, expiration date reported as 30-JUL-2021) for prophylaxis administered by a medical assistant inadvertently (expired product administered). There was no temperature excursions for this vaccine. The outcome of expired product administered was unknown. No other adverse events reported.
seizure; This spontaneous case was reported by a patient and describes the occurrence of SEIZURE (seizure) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The patient's past medical history included Stroke in 2020. Concurrent medical conditions included Penicillin allergy.    In January 2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2022, the patient experienced SEIZURE (seizure) (seriousness criterion medically significant). At the time of the report, SEIZURE (seizure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Patient had 4 seizures between Jan 2022 and Feb 2022. The first seizure happened after the first dose of Moderna Covid-19 vaccine. He did not have vaccination card to provide details of their vaccine. He received the first Moderna Covid19 vaccine in Jan 2022. He not tested positive for Covid at any point. He was on blood pressure pill and heart medication. He had a mild stroke in 2020 and recovered from it. He was scared to get another vaccine.    Treatment medication not reported. Company Comment This spontaneous case concerns a 72-years-old-male patient, with medical history of  Stroke in 2020, concurrent medical condition Penicillin allergy who experienced the seriousness medically significant unexpected AESI of seizure unknown days after 1st. dose of  mRNA-1273 vaccine. He had 4 seizures between Jan 2022 and Feb 2022; the first one happened after the mentioned dose. Treatment medication not reported. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Pain in shoulder left but went up back to hips and down to knees Toes fingers for over two weeks only while laying flat or in chair.
Started symptoms on 06/08/2021; cough, sore throat, headache, and nasal congestion.
36mins post vaccination pt reports post nasal drip and pressure in the ears. Vitals: 131/71, 82, 20, 100% Pt voiced complaints at the end of observation time.  Pt feels that post nasal drip and pressure in the ears are new after vaccine was administered.  Pt was given 25mg PO Benadryl and was instructed to call 911 if having any respiratory distress or symptoms worsen.  Pt's parents picked up the patient so she does not have to drive.  NO swelling of lips or tongue.  No S/S of distress.  Prior to D/C pt reports symptoms have improved and has no further complaints.  Pt released in stable condition.
Severe acute vertigo. Projectile vomiting. Lasting intermittently a few hrs.
Patient under 65 received Fluad QIV; Very sore arm; Headache; This spontaneous case received on 05-Nov-2020 from other health professional (nurse) via Agency (reference number: SEQW20-04842) and concerned a 38-year-old, male patient.   The patient had no relevant medical history. The patient's concomitant medications were not reprorted.   On 29-Sep-2020, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, MF59, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid) (explicitly coded as 'Inappropriate age at vaccine administration') for influenza prophylaxis. The batch number reported was 286592.   On an unknown date in 2020, an unspecified amount of time after receiving Fluad Quadrivalent, the patient experienced very sore arm and headache. The patient was treated with ibuprofen.   The outcome of events 'painful arm' and headache was not reported.   The reporter did not provide causality assessment.   The case was assessed as non-serious.  The case is linked to the cases 202004845, 202006068, 202006069, 202006072, 202006074, 202006077, 202006080, 202006081, 202006085, 202006086, 202006087, 202006089, 202006090, 202006091, 202006092, 202006095, 202006097 and 202006098 (the same reporter).  Company comment: A 38-year-old, male patient was vaccinated with Fluad Quadrivalent. An unknown amount of time after receiving Fluad Quadrivalent, the patient developed pain in extremity and headache. With information available, causal role of the suspect vaccine is assessed as possibly related. Product administered to patient of inappropriate age is assessed as not related, per company's conventions.; Sender's Comments: A 38-year-old, male patient was vaccinated with Fluad Quadrivalent. An unknown amount of time after receiving Fluad Quadrivalent, the patient developed pain in extremity and headache. With information available, causal role of the suspect vaccine is assessed as possibly related. Product administered to patient of inappropriate age is assessed as not related, per company's conventions.
Subsequent to receiving two doses of varicella virus vaccine live the pt's laboratory evaluation revealed negative titer. It was noted that the pt has indeterminate antibodies of varicella.
Headache, Myalgia, Fever & Diarrhea Narrative:  diarrhea, body aches, fever and  headaches; sore arm x 3 d
Panic Attacks, Tachycardia. Syncope, Head Injuries, Concussions. Seizures. Convulsions. POTS (Postural Orthostatic Tachycardia Syndrome). Depression. Anxiety. Neurological Problems. Tremors.